Lisa von Moltke - Mar 17, 2025 Form 3 Insider Report for Zenas BioPharma, Inc. (ZBIO)

Signature
By: /s/ Chase Jayasekera, Attorney-in-Fact
Stock symbol
ZBIO
Transactions as of
Mar 17, 2025
Transactions value $
$0
Form type
3
Date filed
3/21/2025, 04:01 PM
Previous filing
Feb 19, 2025
Next filing
Apr 17, 2025

No securities are beneficially owned.

Remarks:

Head of Research and Development and Chief Medical Officer. Exhibit List: Exhibit 24 - Power of Attorney.